New nanoparticles can perform gene-editing in the lungs: Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.